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Introduction
Clathrin is composed of trimerized heavy chains (CHCs) with 
bound light chains (CLCs) and assembles to form a membrane 
coat. The clathrin lattice formation on cellular membranes is 
initiated by clathrin adaptors that are drawn into the lattice and 
trigger clathrin-coated vesicle (CCV) budding at various sub-
cellular compartments (Pearse and Robinson, 1990; Kirchhausen, 
1999; Brodsky, 2012). Once the invagination process has initi-
ated, dynamin family members associate with the neck of the 
forming pit, recruit additional proteins including actin, and 
allow the scission of the coated vesicle (Fujimoto et al., 2000; 
Merrifield et al., 2002). The role of dynamin 2 (DNM2) in skel-
etal muscle has received considerable attention because the 
autosomal-dominant form of centronuclear myopathy (CNM) 
has been linked to mutations in the DNM2 gene (Bitoun et al., 
2005). DNM2 is involved in various cellular processes, but to 
date it remains unclear whether its role in CCV fission is impli-
cated in centronuclear myopathy.
Several recent studies have proposed a role for clathrin 
and dynamin in actin organization that is distinct from coated 
vesicle formation (Schafer et al., 2002; Veiga et al., 2007; 
Saffarian et al., 2009; Bonazzi et al., 2011, 2012). Intriguingly, a 
role for clathrin in myofibril assembly was previously proposed 
(Kaufman et al., 1990), and several teams have reported di-
rect protein–protein interaction between CHC, -actinin, and 
vinculin, two focal adhesion proteins crucial for muscle func-
tion (Schook et al., 1979; Burridge et al., 1980; Merisko, 1985; 
The ubiquitous clathrin heavy chain (CHC), the main component of clathrin-coated vesicles, is well char-acterized for its role in intracellular membrane traf-
fic and endocytosis from the plasma membrane (PM). 
Here, we demonstrate that in skeletal muscle CHC regu-
lates the formation and maintenance of PM–sarcomere 
attachment sites also known as costameres. We show that 
clathrin forms large coated lattices associated with actin 
filaments and the muscle-specific isoform of -actinin at 
the PM of differentiated myotubes. Depletion of CHC in 
myotubes induced a loss of actin and -actinin sarcomeric 
organization, whereas CHC depletion in vivo induced a 
loss of contractile force due to the detachment of sarco-
meres from the PM. Our results suggest that CHC contrib-
utes to the formation and maintenance of the contractile 
apparatus through interactions with costameric proteins 
and highlight an unconventional role for CHC in skeletal 
muscle that may be relevant to pathophysiology of neuro-
muscular disorders.
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muscle costamerogenesis and costamere maintenance. We 
show that clathrin associates with -actinin at the surface of 
myotubes and forms large plaques that are associated with actin 
filaments. Depletion of CHC induces severe defects in -actinin 
distribution and subsequently leads to defective costamere for-
mation in vitro and induces impairment of contractile properties 
associated with structural abnormalities including sarcomere 
disorganization as well as detachment of the sarcomeres from 
the sarcolemma in vivo.
Results
CHC is a component of the costameric 
complex in skeletal muscle
In adult skeletal muscle, DNM2 and CHC are both localized 
at the level of the I-band and present a striated pattern that over-
laps with the muscle-specific -actinin (isoform 2) staining 
Merisko et al., 1988; Fausser et al., 1993). -Actinin and vinculin 
are expressed in both skeletal and cardiac muscles, where they are 
localized to a specialized compartment called the “costamere.”
Costameres, muscle-specific adhesion sites, are sub- 
sarcolemmal protein assemblies circumferentially aligned in 
register with Z-disks of peripheral myofibrils. They were origi-
nally described as electron-dense plaques rich in the focal adhe-
sion protein vinculin, and function as attachment complexes 
(Pardo et al., 1983a,b; Shear and Bloch, 1985). They are located 
between the plasma membrane and myofibrils and play both a 
mechanical and a signaling role during contraction, transmit-
ting force from the contractile apparatus to the ECM in order 
to stabilize skeletal muscle fibers. They are considered as the 
“Achilles’ Heel” of skeletal muscle because, when disrupted, 
they directly contribute to the development of several distinct 
myopathies (Blake et al., 2002; Ervasti, 2003). In the present 
work, we have addressed the role played by CHC in skeletal 
Figure 1. CHC association with -actinin2 in adult skeletal muscle. (A) Confocal sections of mouse skeletal muscle were processed for double-immuno-
fluorescent labeling of DNM2 (red) and -actinin (green) or CHC (red) and -actinin (green). Bars, 10 µm. (B) The fluorescence intensity as a function 
of distance on the fiber was plotted for eight successive striations, and was reported on the graph for each labeling. The green curve corresponds to the 
green immunolabeling, and the red curve corresponds to the red labeling. (C and D) CHC localization in mouse dissociated FDB fibers. (C) Confocal sec-
tions of fibers processed for immunofluorescent labeling with the monoclonal antibody against CHC (X22, green). Bars: (main panel) 10 µm; (inset) 2 µm. 
(D) XZ and YZ projections of confocal optical sections illustrated in C. Bars, 10 µm. (E) Immunoblot of proteins associated with CHC, -actinin (isoform 
2), vinculin, or control immunoprecipitates from mouse muscle lysates and 1–5% lysate input. Bands for coimmunoprecipitated CHC, -actinin (isoform 2), 
vinculin, talin, or CLC are indicated at the right.
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amounts of vinculin and talin. Additionally, minor amounts of 
-actinin are detected upon clathrin immunoprecipitation while 
vinculin coimmunoprecipitates talin efficiently and some -
actinin, but not clathrin. This suggests that part of the -actinin 
pool is associated with clathrin in a complex distinct from the 
vinculin–talin–-actinin complex.
We further characterized the sites of interaction between 
CHC and -actinin during the early steps of differentiation 
in primary myotubes and showed that these proteins partially 
colocalize along the plasma membrane (PM) after 4 d of differ-
entiation (Fig. 2 A). By subcellular fractionation, we observed 
an association between -actinin and CHC in the PM fraction 
of fibroblasts, myoblasts, and differentiated myotubes. This 
association was stronger in differentiated myotubes as the levels 
of -actinin expression increase (Fig. 2, B and C). In addition, 
we detected -actin in both CHC and -actinin immunoprecipi-
tates from muscle cells. Several adaptor proteins are required 
(Fig. 1, A and B; Kaufman et al., 1990; Butler et al., 1997; 
Towler et al., 2004; Durieux et al., 2010; Cowling et al., 2011). 
Using confocal optical sectioning and 3D reconstruction, we 
demonstrated that this striated labeling was mainly present at 
the surface of dissociated fibers (Fig. 1, C and D). Analysis of 
the compartment labeled by anti-CHC antibodies on adult skel-
etal muscle using electron microscopy revealed that clathrin is 
present along the sarcolemma and localizes at sites that corre-
spond to contacts between sarcolemma and Z-discs, which are 
also densely stained with tannic acid (Fig. S1, A and B). As 
several studies have described a direct association between 
-actinin and vinculin with clathrin (Schook et al., 1979; Burridge 
et al., 1980; Merisko, 1985; Merisko et al., 1988; Fausser et al., 
1993), we then assessed the association between clathrin and 
the -actinin–vinculin–talin complex in adult mouse skeletal 
muscle (Fig. 1 E). We observed coimmunoprecipitation of CHC 
and CLC upon -actinin immunoprecipitation, but only minor 
Figure 2. CHC association with -actinin2 and actin at the PM of differentiated myotubes. (A) Localization of -actinin (green) and CHC (red) in mouse 
primary myotubes differentiated for 4 d. Inset in Overlay panel is displayed on the right. (B) Immunoblot analysis of proteins associated with CHC or 
control immunoprecipitates from subcellular fractions (plasma membrane, PM and cytosol, CYT) of 3T3 fibroblasts (FB), undifferentiated C2C12 (MB), and 
differentiated C2C12 cells (MT). (C) Immunoblot analysis of proteins associated with -actinin or control immunoprecipitates from subcellular fractions (PM 
and CYT) of 3T3 fibroblasts (FB), undifferentiated C2C12 (MB), and differentiated C2C12 cells (MT). (D) Confocal microscopy of AP2 (green) and CHC 
(red) in differentiated C2C12 skeletal muscle cells. The left panel displays images from the top of the myotube and the right panel displays images from 
the middle of the myotube. Arrows indicate large clusters of colocalization between AP2 and CHC and arrowheads indicate intracellular clusters near the 
nuclei positive for CHC and negative for AP2. (E) XZ and YZ projections of serial confocal sections are shown on the overlay. Bar, 10 µm.
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deep-etch rotary replication and electron microscopy (Heuser, 
1980). We showed that clathrin forms two distinct coated struc-
tures, i.e., large plaques that contain much more polymerized 
clathrin that would be required to form a single vesicle (pseudo-
colored in red in Fig. 3, D and F) and coated vesicles found in 
regions devoid of plaques (Fig. 3, D and F; and Fig. S1, C–G). 
Using clathrin antibodies we were able to confirm that CHC 
was indeed the proteinaceous material composing these struc-
tures (Fig. S1, C–K). As expected, -actinin strongly labeled 
dense longitudinally organized actin filament bundles (Fig. 3 D, 
arrows; and Fig. S2, A and B) that are reminiscent of the 
contractile apparatus. In addition, -actinin was associated 
with actin filaments that surround or overlap flat clathrin lat-
tices (Fig. 3, E and G; and Fig. S2, A, C, and D) highly en-
riched with the adhesion marker 5 integrin (Fig. S2, E–H) 
as previously described on rat myotubes (De Deyne et al., 1998; 
Pumplin, 1989; Pumplin and Bloch, 1990), whereas vinculin was 
not localized at these clathrin-coated plaques (unpublished data). 
for targeting clathrin to specific intracellular compartments and, 
among these, AP2 is involved in recruiting clathrin to the PM. 
In differentiated myotubes, AP2 was localized at the surface 
of myotubes and displayed a predominant PM localization 
(Fig. 2, D and E). These results show that clathrin is a costa-
meric protein that is recruited by AP2 and associates with actin 
and -actinin at the PM of differentiated myotubes.
Costameric clathrin forms large plaques 
where -actinin and actin are localized
Myofibril assembly and subsequent sarcomere formation initi-
ate at the PM. After the formation of a subcortical actin lattice, 
additional nascent sarcomeres keep adding to the initial actin 
network (Dlugosz et al., 1984; Epstein and Fischman, 1991; 
Sanger et al., 2002; Quach and Rando, 2006). We hypothesized 
that -actinin and actin rely on a clathrin scaffold at the PM to 
start recruiting additional myofibrils and explored this possibility 
using immunogold cytochemistry coupled with quick-freeze, 
Figure 3. -Actinin and actin are localized on large flat clathrin-coated plaques. (A–C) Immunofluorescent staining of -actinin (A), CHC (B), and merged 
images (C) in untreated differentiated primary mouse myotubes visualized using confocal microscopy. Bars, 5 µm. (D–G) Adherent plasmalemmal sheets 
prepared from control primary myotubes differentiated for 4 d and labeled with -actinin antibodies followed by secondary antibodies conjugated to 
18-nm colloidal gold particles. Gold particles are pseudocolored yellow (D–G) and clathrin lattices are pseudocolored pale red (D and F). The boxed 
region in D and F is magnified in E and G, respectively. Note that -actinin is found on both actin cables (D, arrows) and branched filaments lying on top 
of flat clathrin-coated lattices. Bars, 100 nm.
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As expected, control myotubes present a striated -actinin 
distribution after 6 d of differentiation. This striated pattern is first 
visible at the periphery of the myotube and gradually fills the entire 
cytoplasm (Quach and Rando, 2006). In CHC-depleted myotubes, 
the -actinin striated pattern was strongly disrupted, and instead, 
clusters of -actinin were randomly dispersed in the intracellular 
space (Fig. 4 C). 3D projections of confocal sections confirmed a 
dramatic reduction of the striated pattern between controls and 
CHC-depleted myotubes (Fig. 4 D). Upon CHC depletion, a simi-
lar phenotype arises in mouse primary myotubes (Fig. 4, E and F) 
in which organization of actin filaments is also affected. To deter-
mine the role played by clathrin during the early steps of costamere 
formation, we performed siRNA depletion experiments on C2C12 
myotubes after 4 d of differentiation, before -actinin and actin 
could reach a striated organization. In control myotubes, -actinin 
Our experiments on primary myotubes show that CHC forms 
large plaques that may serve to anchor the actin cytoskeleton 
and -actinin.
CHC is required for the formation  
of costameres
We next tested the effect of CHC knockdown on -actinin sub-
cellular organization. We achieved high knockdown efficiency in 
C2C12 myotubes differentiated for 6 d (Fig. 4, A and B) with two 
previously published siRNA sequences (Ezratty et al., 2009). 
Additionally, we showed that levels of CLC were also reduced be-
cause of the instability of the light chain upon heavy chain deple-
tion, as previously reported in nonmuscle cells (Brodsky, 1985; 
Esk et al., 2010). Expression levels of -actinin, vinculin, and talin 
were unaffected in myotubes treated with CHC siRNA (Fig. 4 A).
Figure 4. CHC regulates formation and or-
ganization of sarcomeres in cultured myo-
tubes. (A) Differentiated C2C12 cells were 
treated with control GAPDH siRNA, two dif-
ferent siRNA targeting CHC, a mixture of 
both (CHC-1, CHC-2, CHC-1+2 indicated at 
the top), and cell lysates immunoblotted for 
proteins (indicated at the right). (B) CHC ex-
pression in cultured C2C12 myotubes treated 
with GAPDH or CHC siRNA. The graph de-
picts quantification of CHC band intensity 
(n = 8 for CHC-1 and n = 4 for CHC-2 and 
CHC1+2; data are presented as mean ± SEM; 
**, P < 0.01). (C) -Actinin staining in differen-
tiated C2C12 skeletal muscle cells treated with 
control GAPDH siRNA or CHC siRNA. DNA 
staining (DAPI blue) identifies multinucleated 
myotubes. The boxed region in the merged 
images is magnified in the insets. Bars: (main 
panels) 30 µm; (insets) 10 µm. (D) XZ and YZ 
projections of serial confocal sections. Bars, 
10 µm. (E) CHC depletion on cultured primary 
mouse myotubes. Immunofluorescent staining 
of -actinin (green) and actin (red) in differ-
entiated primary mouse myotubes treated with 
control GAPDH siRNA or CHC siRNA. DNA 
staining (DAPI blue) identifies differentiated, 
multinucleated myotubes. The boxed region in 
the merged images is magnified in the insets. 
Bars: (main panels) 20 µm; (insets) 10 µm. 
(F) Quantification of striated vs. nonstriated 
surface in control (siRNA against GAPDH) or 
in myotubes treated with siRNA against CHC 
(n = 30–60 myotubes, data are presented as 
mean ± SEM; **, P < 0.01).
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not due to perturbations of the secretory pathway or trafficking 
between the endo/lysosomal system.
DNM2 is also present at or near the plasma membrane of 
differentiating myotubes, where its staining partially overlaps 
with that of -actinin (Fig. S4 C). AP2 depletion strongly re-
duced the amount of DNM2 at the plasma membrane, suggest-
ing that part of the PM staining corresponds to an association 
with clathrin lattices (Fig. S4 D). Efficient DNM2 depletion 
(Fig. S3 A) induced an increase in the amount of intracellular 
-actinin staining (Fig. 5 and Fig. S4 A). Of interest, these 
intracellular aggregates observed upon CHC, AP2, and DNM2 
depletion also contain actin aggregates (Fig. S4 A).
We performed the quantification of the intracellular 
-actinin–positive area for all siRNA constructs (Fig. 5 B). CHC, 
AP2, and DNM2 had a strong impact on the intracellular 
-actinin area, whereas AP1 and AP3 values were not different 
from controls. Altogether, these results confirm that the primary 
impact observed upon CHC depletion on -actinin organization 
is related to its cytoskeleton scaffolding role at the PM through 
a process also involving AP2 and DNM2.
Hip1R depletion stabilizes -actinin and 
actin on clathrin-coated structures
Actin has been shown to be present at CCVs (Collins et al., 
2011), and a requirement for actin has been suggested for clathrin 
was mainly localized along the PM. In stark contrast, myotubes 
that had been depleted of CHC presented a strong increase in the 
amount of intracellular -actinin (Fig. 5 A). These results demon-
strate that CHC is required for proper -actinin distribution during 
early myotube differentiation.
AP2 and DNM2 are required for -actinin 
scaffold formation
We next tested the effect of AP2 knockdown on -actinin 
subcellular localization. AP2 (-subunit) depletion by siRNA 
(Fig. S3 C) induced a strong decrease in the amount of CHC 
recruited at the PM. More importantly, AP2 knockdown phe-
nocopied the effect of CHC depletion on -actinin distribution 
and dramatically increased the intracellular -actinin staining 
(Fig. 5). We have also depleted the AP1 (-subunit) and AP3 
(-subunit) adaptors responsible for CHC targeting at the Golgi 
apparatus and endosomal systems. As expected, AP1 and AP3 
were localized at the perinuclear region and in intracellular 
structures dispersed throughout the myotube (Fig. S3 A). 
siRNA depletion of AP1 and AP3 drastically reduced the intra-
cellular CHC staining without affecting CHC localization at 
the PM (unpublished data). Moreover, knockdown of AP1 and 
AP3 had no effect on -actinin distribution (Fig. 5), suggesting 
that the impact of CHC depletion on -actinin organization is 
Figure 5. CHC, AP2, and DNM2 but not AP1 
or AP3 depletion in cultured mouse myotubes 
perturbs -actinin distribution before striations 
appear. (A) Differentiated C2C12 myotubes 
were treated with siRNA targeting proteins (in-
dicated at the left). Immunofluorescent staining 
of -actinin in myotubes treated with control 
siRNA against GAPDH or siRNA targeting ei-
ther CHC, AP1, AP2, AP3, or DNM2. DNA 
staining (DAPI blue) identifies differentiated, 
multinucleated myotubes. The boxed region 
in the merged images is magnified in the in-
sets. Bars: (main panels) 10 µm; (insets) 5 µm. 
(B) Quantification of -actinin fluorescence 
surface as a function of total myotube surface 
in 4-d differentiated myotubes treated with 
siRNA against GAPDH, CHC, AP1, AP2, AP3, 
or DNM2 (n = 30–50 myotubes, data are pre-
sented as mean ± SEM; **, P < 0.01).
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Hip1R-depleted myotubes accumulated unusual actin structures 
near the cell cortex (Fig. 6). These structures, which are very simi-
lar to the ones observed by Engqvist-Goldstein et al. (2004) upon 
Hip1R depletion in HeLa cells, took a variety of forms, including 
tails and rings at the bottom and the top of differentiated myotubes 
(Fig. 6 and Fig. S4 B). These results demonstrate that when Hip1R 
expression is reduced, actin polymerization at clathrin-coated 
structures is no longer properly regulated and results in accumula-
tion of actin and -actinin on clathrin-coated plaques.
CHC is required for sarcomere 
maintenance in mature isolated  
muscle fibers
We then assessed the function of CHC in mature skeletal mus-
cle fibers. For this purpose, we developed an AAV strategy com-
bined with the use of a short hairpin RNA (shRNA) against 
CHC (AAV-shCHC) for ex vivo transduction of isolated fibers 
plaque formation (Saffarian et al., 2009). Interaction between 
actin and clathrin is mediated by Hip1R (huntingtin-interacting 
protein 1–related protein) and CLC (Engqvist-Goldstein et al., 
2001, 2004; Chen and Brodsky, 2005; Legendre-Guillemin et al., 
2005; Brodsky, 2012). In myotubes, Hip1R colocalizes with 
AP2-positive puncta in differentiated myotubes (Fig. S3 D). We 
tested the effect of both CHC and AP2 depletion on Hip1R 
(Fig. S3 D) and showed a dramatic reduction of the Hip1R 
staining at the PM. These results confirm that CHC and AP2 are 
required for recruiting the clathrin-associated actin-binding pro-
tein Hip1R to the PM. It has been shown that Hip1R depletion sta-
bilizes the actin filaments on clathrin-coated plaques in HeLa cells 
(Engqvist-Goldstein et al., 2004). We decided to test the contribu-
tion of Hip1R on the distribution of actin and -actinin in differ-
entiated myotubes. siRNA depletion of Hip1R drastically reduced 
Hip1R protein levels (Fig. S3 A). Hip1R-depleted myotubes had 
a disorganized actin cytoskeleton and -actinin distribution. The 
Figure 6. Hip1R depletion in cultured myotubes stabilizes actin and -actinin on clathrin-coated structures. (A) Immunofluorescent staining of -actinin 
(green) and Hip1R (red) in differentiated C2C12 myotubes treated with control siRNA against GAPDH or siRNA targeting Hip1R. DNA staining (DAPI 
blue) identifies differentiated, multinucleated myotubes. The boxed region in the merged images is magnified in the insets. Bars: (main panels) 10 µm; 
(insets) 5 µm. (B) -Actinin localization in differentiated C2C12 skeletal muscle cells treated with siRNA targeting Hip1R. The left panel displays an image 
from the bottom of the myotube and the right panel displays an image from the top of the myotube. The boxed regions in the images are magnified in the 
insets 1 and 2. Bars: (main panels) 10 µm; (insets) 5 µm. (C) Immunofluorescent staining of actin and CHC in myotubes treated with control siRNA against 
GAPDH or siRNA targeting Hip1R. DNA staining (DAPI blue) identifies differentiated, multinucleated myotubes. The boxed region in the merged images 
is magnified in the insets. Bars: (main panels) 10 µm; (insets) 5 µm. (D) Actin localization in differentiated C2C12 skeletal muscle cells treated with siRNA 
targeting Hip1R. The left panel displays an image from the bottom of the myotube and the right panel displays an image from the top of the myotube. The 
boxed regions in the images are magnified in the insets (1 and 2) and include CHC staining (red). Bars: (main panels) 10 µm; (insets) 5 µm. Arrows in A, 
C, and D indicate large peripheral clusters of -actinin or actin and CHC.
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2011). In fibers depleted of CHC, the DNM2 signal at the 
core of the fiber was greatly reduced at the PM (Fig. 7 E). To 
assess the effect of CHC depletion on the integrity of the actin 
cytoskeleton we used phalloidin staining. In control fibers, F-actin 
displayed a regularly spaced striated distribution. However, CHC-
depleted fibers presented a diffuse actin distribution (Fig. 7 F), 
and in some fibers detachment of entire sarcomeric bundles 
(Fig. 7 G). In addition to its role in costamerogenesis, these data 
suggest that CHC is also involved in their preservation in 
mature fibers.
from flexor digitorum brevis (FDB) muscle. In AAV-shCHC–
infected fibers, a strong decrease in CHC expression was con-
firmed, both at the RNA and protein level (Fig. 7, A–C), and 
-actinin was no longer correctly localized, with very few 
striations noticeable and displaying a diffuse or disorganized 
staining pattern (Fig. 7 D). We also tested the effect of CHC 
depletion on DNM2 distribution. In control fibers, DNM2 dis-
played a striated pattern at the surface, with each striation being 
centered on the I-band, and in the core of the fiber DNM2 was 
mainly present at the PM (Durieux et al., 2010; Cowling et al., 
Figure 7. CHC is required for sarcomere 
maintenance in adult fibers. (A) Quantitative 
RT-PCR and (B) Western blot analysis of CHC 
levels and proteins indicated at the right in 
FDB fibers infected with AAV-CTRL or AAV-
shCHC for 12 d in vitro. (C) Quantification of 
Western blot CHC band intensity (n = 3, data 
are presented as mean ± SEM; for A and C: 
**, P < 0.01). (D–G) Confocal microscopy of 
dissociated FDB fibers infected with AAV-CTRL 
or AAV-shCHC for 12 d and co-stained with 
antibodies against either -actinin and CHC 
(D), -actinin and DNM2 (E), or F-actin (phal-
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2006) in CHC-depleted skeletal muscle by immunocytochem-
istry. At 18 d PI, the -actinin labeling was not different from 
the control, whereas a clear reduction in sarcolemmal clathrin 
was apparent (Fig. 9 A). However, at day 21 and at further 
time points (day 23 and day 25), -actinin and -actin both 
displayed a diffuse distribution compared with control muscle, 
and areas where -actinin was no longer adjacent to the sarco-
lemma were also visible (Fig. 9, B–D). In addition, in control 
fibers DNM2 presented a strong PM staining and a weak intra-
cellular staining. At day 21 and at further time points (day 23 
and day 25) the DNM2 intracellular staining was greatly en-
hanced (Fig. 9, B and D). We also tested the effect of CHC 
depletion on the distribution of other costameric proteins such 
as dystrophin, -dystroglycan, and caveolin-3 (Fig. S5, B and C). 
Even though at days 23 and 25 the muscle presented a severe 
dystrophic phenotype, no change in the distribution of these 
proteins was noticeable. We therefore conclude that CHC 
depletion has a strong effect on the localization of intracellu-
lar costameric proteins related to the actin cytoskeleton, in-
cluding -actin, actin-associated proteins, and DNM2, without 
affecting the distribution of dystrophin and PM integral 
components such as members of the dystrophin-associated glyco-
protein complex.
In vivo CHC depletion induces 
disorganization of the contractile 
apparatus and detachment between  
the sarcolemma and myofibrils
We performed electron microscopy analysis of CHC-depleted 
muscle at day 18 PI (without phenotype upon HE analysis) and at 
day 25 PI (peak of degeneration). At day 18 PI, focal regions dis-
played sarcomere abnormalities such as Z-band streaming and dis-
organization of the contractile apparatus especially in the I-band 
region (Fig. 10, A–C). It is of interest that these focal sarcomeric 
disorganizations were usually found adjoining the sarcolemma. In 
addition, at day 18 PI, occasional detachments of the sarcomeric 
apparatus from the sarcolemma were visible (Fig. 10, E–G). Both 
these phenotypes were consistent with the phenotypes produced 
upon clathrin depletion on isolated fibers. Of note, the T-tubule and 
sarcoplasmic reticulum system did not seem affected in the disor-
ganized regions (Fig. 10 D). At day 25 PI, both transverse (Fig. 10, 
H–J) and longitudinal sections (Fig. 10, K and L) presented a par-
ticularly exacerbated detachment phenotype, with fibers displaying 
large areas of the sarcolemma that were no longer associated with 
sub-sarcolemmal sarcomeres.
Discussion
In this study, we identify a new role for CHC in costamere for-
mation and maintenance. Our results raise the possibility that 
CHC, AP2, and DNM2 contribute to the formation of the costa-
meric scaffold that is necessary for anchoring the actin cyto-
skeleton by recruitment of actin-binding protein Hip1R and 
actin cross-linking protein -actinin early during myotube dif-
ferentiation. Consequently, depletion of CHC, by perturbing the 
actin cytoskeleton and redistributing -actinin, has a strong 
effect on the formation and maintenance of the contractile 
In vivo CHC depletion impairs force and 
causes muscle degeneration
We used AAV-shCHC in order to induce an in vivo depletion of 
CHC in tibialis anterior (TA) muscle. By performing hematoxy-
lin and eosin staining on transverse TA sections (Fig. 8 A), no 
histological change was visible in muscles injected with control 
AAV or with AAV-shCHC until day 18 post-injection (PI). 
However, fibers displaying a rounded shape with a clearly 
disorganized intracellular space were noticed at day 21 PI. 
Between days 21 and 23 PI some degenerating fibers appeared, 
and by day 25 PI the vast majority of the fibers had a rounded 
shape with a clear degenerating phenotype. As a general feature 
of muscle degeneration, an immune infiltration was visible at 
day 21 and was extremely pronounced by days 23 and 25 PI. At 
day 25, small myotubes appeared and their presence reached a 
peak by day 38 where the majority of the muscle was cen-
trally nucleated, the signature of a muscle undergoing mas-
sive regeneration.
Quantitative RT-PCR and Western blot analysis confirmed 
that at day 18 PI a strong decrease in CHC had indeed occurred 
(Fig. 8, B–D). When we measured CHC RNA and protein levels 
at later time points, we noticed that CHC levels increased from 
40% back to 55% of control levels at day 21 PI and were back to 
control levels by day 23. Surprisingly, at day 25 PI, CHC levels 
were higher in the AAV-shCHC–injected muscle compared with 
the contralateral control muscle (Fig. 8, B and C). A possible ex-
planation is that the infiltration by macrophages contaminates our 
analysis with exogenous clathrin from nontransduced immune 
cells. Indeed, at days 21, 23, and 25 PI a strong increase in CD11b 
protein levels was evident (Fig. 8 C and Fig. S5, A and B). 
Immunofluorescent staining confirmed that CD11b-positive 
macrophages had massively infiltrated the CHC-depleted muscle. 
In fact, CD11b protein levels correlated perfectly with the sudden 
increase in CHC levels. To circumvent the immune infiltration 
and to show that a clathrin knockdown had occurred, we per-
formed immunoprecipitation experiments using antibodies 
against the muscle-specific -actinin isoform. This assay enabled 
us to show that in muscles injected with AAV-shCHC, there was 
a strong decrease in the amount of CHC which coimmunoprecip-
itated with -actinin (Fig. 8 E).
Direct muscle stimulation was performed in order to mea-
sure the maximal isometric strength of the TA muscle in CHC-
depleted muscles. At day 18 PI, when no morphological 
alteration could be observed, CHC depletion induced a 57% de-
crease in specific maximal force, i.e., absolute maximal force 
divided by muscle weight (Fig. 8 F). At day 21 PI, CHC deple-
tion had an even more robust effect; muscle depleted of CHC 
displayed a 74% decrease in specific maximal force (Fig. 8 F). 
No significant muscle mass loss was observed at both early time-
points (Fig. 8 G). These results show that AAV-shCHC efficiently 
knocks down CHC in vivo with dramatic consequences in terms of 
muscle fiber homeostasis.
In vivo CHC depletion perturbs -actinin,  
-actin, and DNM2 distribution
We then sought to analyze the distribution of -actinin, DNM2, 
and the costameric actin isoform -actin (Sonnemann et al., 
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Figure 8. CHC depletion using AAV-shCHC in vivo impairs force and causes muscle degeneration. (A) Hematoxylin and eosin staining of AAV-CTRL– or 
AAV-shCHC–injected muscle at day 18, 21, 23, 25, and 38 after virus injection. (B) RT-qPCR of CHC mRNA levels at different time points after AAV-CTRL 
or shCHC AAV injection (n = 2–9 mice, data are presented as mean ± SD; *, P < 0.05; **, P < 0.01). (C) CHC protein levels at different time points 
after AAV-CTRL or shCHC AAV injection. The full time-course of CD11b levels, including the D23 and D25 time points shown here, is shown in Fig. S5 A. 
(D) Quantification of Western blot CHC band intensity (n = 4 mice at day 18, data are presented as mean ± SEM; *, P < 0.05; Mann-Whitney U test). 
(E) Immunoblot analysis of proteins associated with -actinin or control immunoprecipitates of TA muscle lysates injected with AAV expressing a control 
construct or AAV expressing shCHC at 21 d after injection. (F and G) Measures of the specific maximal force (F) and of the muscle weight (G) of isolated 
TA muscle injected with AAV expressing a control construct or AAV expressing the shCHC construct (n = 3–5 mice) at either 18 or 21 d after injection. 
Data are presented as means ± SEM; for F: *, P < 0.05; **, P < 0.01.
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cultured adipocytes (Bellve et al., 2006) and we observe them 
on non-adherent regions such as the top or the sides of myo-
tubes (Fig. 2 D and Fig. S4 B). Because one putative role for 
clathrin-coated membrane domains is to maintain the stable at-
tachment to the substrate, we suggest that clathrin plays the 
same role at the costamere, which is the muscle-specific ad-
hesion site.
These large clathrin-coated plaques are also endocytically 
active, and invaginated pits are frequently observed at their 
edges. The implication of both CHC and DNM2 in focal adhe-
sion turnover has previously been reported (Ezratty et al., 2005, 
2009). Therefore, one may hypothesize that this protein com-
plex responsible for formation and maintenance of the costa-
meres is also involved in the turnover of these structures by 
endocytosis. In addition, we cannot exclude that the defects we 
are observing both in vitro and in vivo are at least partially due 
to defective endocytosis of costamere components. However, 
because (a) plaques in myotubes contain much more polymer-
ized clathrin than would be required to form a single vesicle, 
(b) adhesion inhibits clathrin-mediated endocytosis (Batchelder 
and Yarar, 2010), and (c) endocytosis is reduced during differ-
entiation (Kaisto et al., 1999), the defects we are observing 
apparatus. The possibility that we are observing defective 
-actinin trafficking inside the cell toward the PM is improbable 
because -actinin is not a membrane-associated protein, does 
not colocalize with clathrin in intracellular compartments, and 
because AP1 and AP3 knockdown does not induce an -actinin 
redistribution phenotype. In fact, our results clearly point to-
ward a defect in the attachment of -actinin to the cytoplas-
mic side of the PM and raise the possibility that clathrin is 
involved in actin scaffolding, thereby performing a task similar 
to what has been described for bacterial uptake, adherens 
junctions, and immune synapses (Bonazzi et al., 2011, 2012; 
Calabia-Linares et al., 2011). In addition, our results demon-
strate a predominant role for AP2 in CHC targeting to the PM of 
differentiated myotubes.
The assembly of clathrin in plaques has been previously 
observed in several cell types, including muscle cells, but their 
physiological importance has proven controversial (De Deyne 
et al., 1998; Pumplin, 1989; Pumplin and Bloch, 1990; Akisaka 
et al., 2003; Bellve et al., 2006; Saffarian et al., 2009) and their 
functional role is still not clear. They were thought to represent 
artifacts of cell adhesion of cultured cells. However, large clath-
rin lattices have also been observed in non-adherent floating 
Figure 9. -Actinin, -actin, and DNM2 distribution is perturbed upon in vivo CHC depletion. (A–D) Confocal microscopy on transverse sections of skeletal 
muscle processed for double-immunofluorescent labeling using antibodies against (A) CHC (red) and -actinin (green) at day 18 PI; (B) -actinin (green) 
and DNM2 (red); (C) -actinin (green) and DAPI (blue); (D) and -actin (green) and DNM2 (red) at day 21 PI. The boxed region in the merged images 
is magnified in the insets. Arrowheads point at regions of the fiber where the -actinin staining is no longer associated with the sarcolemma. Bars: (main 
panels) 30 µm; (insets) 20 µm.
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Figure 10. Sarcomeric disorganization and detachment between sarcolemma and myofibrils upon in vivo CHC depletion. Transmission electron micros-
copy of longitudinal (A–D, K–L) and transverse (E–J) muscle sections from mice injected with AAV-shCHC constructs at day 18 (A–G) and day 25 PI (H–L). 
In A–D, the sarcomeric apparatus is disorganized in focal regions adjoining the sarcolemma (within the dotted lines in A) and presents streaming and 
disassembly of the Z-line. C and D are insets of the respective boxed regions in B. In E–G, small detachments between the sarcolemma and the contractile 
apparatus are visible at day 18 PI. At day 25 PI, large detachments are seen in both transverse (H–J) and longitudinal orientation (K–L). I is an inset of the 
boxed region in H; J is an inset of the boxed region in I; L is an inset of the boxed region in K. Arrows in E, H, and L indicate detachments.
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muscle (Cowling et al., 2011), and we show that DNM2 is 
required for proper -actinin organization. Recently, a CNM-
related DNM2 mutation was associated with an accumulation 
of electron-dense material located between disorganized myo-
fibrils as well as DNM2 and CHC mislocalization within the 
atrophied myofiber (Kierdaszuk et al., 2013). In addition, over-
expression of DNM2 mutants in mouse skeletal muscle leads to 
-actinin structural defects with prominent misalignment of the 
Z-line in vivo, which may explain at least in part the reduced 
specific maximal force observed in these mice (Cowling et al., 
2011). All these data associated with the undeniable role of 
DNM2 in regulation of actin cytoskeleton dynamics and focal 
adhesion maintenance (Ezratty et al., 2005, 2009) highlight 
a new putative pathomechanism of DNM2-related CNM that 
merits further investigation.
Overall, our experiments clearly demonstrate the involve-
ment of the CHC, the AP2 adaptor protein, Hip1R, and DNM2 
in the formation of structures that, through association with 
-actinin and actin filaments, allow the organization of the con-
tractile apparatus in close association with the sarcolemma. The 
present study sheds light on a long-standing question, namely, 
the role of clathrin in skeletal muscle sarcomeric structure orga-
nization. Altogether, our results highlight an unconventional, 
novel role for clathrin in striated muscle that may be relevant to 
muscle physiology and whose dysfunction could be associated 
with the physiopathology of CNM linked to DNM2 mutations.
Materials and methods
Antibodies
Anti-CHC mouse monoclonals X22 and TD.1, rabbit polyclonal against 
clathrin light chains (anti-consensus), and mouse monoclonal AP6 (against 
-subunit of AP2) used in this study were produced by Dr. Brodsky’s labora-
tory. The rabbit polyclonal antibody against CHC is from Abcam. For CHC 
detection in immunohistochemistry, immunocytochemistry, and electron mi-
croscopy we used the mouse monoclonal X22 antibody. The rabbit poly-
clonal was used for double-immunofluorescent labeling. Both X22 and the 
rabbit polyclonal anti-CHC completely colocalize. For Western blot experi-
ments, both mouse monoclonal TD.1 and rabbit polyclonal (Abcam) anti-
bodies were used. Other commercial sources of antibodies were as follows: 
mouse monoclonals against -actinin 2, smooth-muscle actin, -actin, vincu-
lin, and talin (Sigma-Aldrich); mouse monoclonal SA4 against AP3 (-subunit 
DSHB); rabbit polyclonal against AP1 (-subunit); rabbit polyclonal anti-
DNM2, rabbit polyclonal anti-integrin 5, rabbit polyclonal anti-GAPDH, 
and rabbit polyclonal anti-CD11b (Abcam); goat polyclonal anti-caveolin3 
(Santa Cruz Biotechnology, Inc.); rabbit polyclonal against dystrophin and 
mouse monoclonal against -dystroglycan (Novocastra); and rabbit poly-
clonal against Hip1R (EMD Millipore). Secondary antibodies for immuno-
fluorescence were from Life Technologies (Alexa Fluor 488, 568, and 633 
conjugates). Secondary antibodies coupled to horseradish peroxidase 
were from Jackson ImmunoResearch Laboratories, Inc.
Muscle tissue lysate
Lysates of whole tissue were prepared from freshly dissected mouse skeletal 
muscle. Tissue was homogenized by dounce in lysis buffer (1 mg/3 ml 50 mM 
Tris-HCl, pH 7.5, 0.15 M NaCl, 1 mM EDTA, 1% NP-40, and 1 protease 
inhibitor cocktail tablet [1:10 ml buffer; Roche]). Homogenate was centri-
fuged for 10 min at 14,000 g, and the pellet discarded to obtain a post-
nuclear supernatant. Protein concentration of the lysate was determined by 
Bradford assay (Bio-Rad Laboratories).
Immunoblot analysis
Protein samples were separated by electrophoresis (4–12% bis-acrylamide 
gel; Life Technologies), then electrophoretically transferred to 0.45-µm 
nitrocellulose membranes (Life Technologies) and labeled with primary 
antibodies and secondary antibodies coupled to horseradish peroxidase. 
are probably not mainly due to endocytosis defects but could 
relate to the scaffolding role of CHC and DNM2 for the actin 
cytoskeleton (Schafer et al., 2002).
Our experiments show that these large clathrin-coated 
structures are intimately associated with the actin cytoskeleton 
and actin-binding proteins such as -actinin. Because vinculin 
and talin were not detected in our coimmunoprecipitation ex-
periments and because vinculin did not localize on clathrin-
coated plaques (unpublished data), we believe that the coated 
domain corresponds to a different entity from classical focal 
adhesion contacts. The detection of clathrin plaques in situ in 
adult skeletal muscle is of great interest but remains technically 
challenging at the moment. It is of interest that costameres have 
been recurrently described as sub-sarcolemmal dense plaques 
(Chiesi et al., 1981; Pardo et al., 1983a,b; Shear and Bloch, 
1985), and therefore it is tempting to speculate that part of the 
density which characterizes these structures could be attributed 
to clathrin plaques.
Early during in vivo clathrin depletion appear signs which 
point toward defects in costamere function. The first phenotype 
attributed to clathrin depletion is the presence of small detach-
ments between the sarcolemma and the underlying myofibrils. 
CHC knockdown induces sarcomeric disorganization with 
streaming of the Z-line, which leads to a drastic and rapid mus-
cle degeneration. Our in vivo experiments confirm the results 
obtained on differentiated myotubes and again point toward a 
role for CHC in the formation of stable plasma membrane com-
partments, which contributes to the attachment of sarcomeric 
lattices. Our results also point toward differences between three 
different costamere complexes. The first is centered on the DGC 
complex, dystrophin, ankyrins, and plectin (Ayalon et al., 2008; 
Randazzo et al., 2013), the second is centered on integrins, 
vinculin, -actinin, and talin (Pardo et al., 1983a,b; Belkin 
et al., 1986), and the third is centered on integrins, -actinin, 
and clathrin plaques (this paper); all three contain branched 
actin filaments. Also, the strong maximal force-loss seen in the 
clathrin-depleted muscle before any significant histological sign 
testifies to the vital role played by clathrin. The fact that more 
than 40% of the direct maximal force is lost before any change 
in total muscle mass or before the appearance of histological 
changes at the photon microscopy level could be attributed to 
the loss of both longitudinal and lateral force transmission in 
these myofibers. This force loss can be a direct consequence 
of both the large areas where disorganization of sarcomeres is 
evident and an uncoupling between the sarcolemma and the un-
derlying contractile apparatus. Although the contribution of a 
trafficking dysfunction cannot be excluded, we believe that 
clathrin plays a structural role at the plasma membrane and that 
first appear signs related to this structural function.
Autosomal-dominant CNM is a rare neuromuscular disor-
der due to mutations in the DNM2 gene (Bitoun et al., 2005). 
The results reported here and previous data suggest that impair-
ment of CHC and DNM2 function in the formation and mainte-
nance of the contractile apparatus via costamere organization 
may be relevant in CNM pathophysiology. Similarly to clathrin, 
DNM2 is mainly localized at the PM and the Z-line, where it 
colocalizes with -actinin in both mouse and human skeletal 
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species) or the two secondary antibodies were added simultaneously at the 
appropriate step. Secondary antibodies were labeled with either Alexa 
Fluor 488 or Alexa Fluor 568.
For myofibers isolated from mouse muscle, immunolabeling was per-
formed directly in the 24-well culture plate. Cells were fixed (15 min, 4% 
paraformaldehyde in PBS at RT), permeabilized (10 min in PBS with 0.5% 
Triton X-100), and immunolabeled using the same procedure described for 
mouse muscle sections.
For mouse cells grown on coverslips, cells were washed in warm 
PBS, fixed in paraformaldehyde (4% in PBS, 15 min), then washed in PBS, 
permeabilized (10 min, 0.5% Triton X-100 in PBS) and blocked in blocking 
solution (5% BSA in PBS with 0.1% Triton X-100, 30 min). Antibody label-
ing was performed by addition of 200 µl blocking solution with primary or 
secondary antibodies (1–5 µg/ml) and washing with PBS with 0.1% Triton 
X-100. Samples were mounted in Vectashield containing DAPI (Vector 
Laboratories).
Muscle sections, mouse cells, and myofibers from mouse muscle 
were analyzed by confocal laser scanning microscopy using an inverted 
operating system (SP2; Leica) equipped with HCX Plan-Apo CS 40×/1.20 
NA and 63×/1.40 NA oil immersion objective lenses. Images presented 
in Figs. 1 A, 5, 6, S3, and S4 were acquired using an upright confocal 
laser scanning microscope (FV-1000; Olympus) equipped with a UPlanS-
Apo 60×/1.35 NA oil immersion objective lens. DAPI, Alexa Fluor 488, 
and Alexa Fluor 568 fluorescence was sequentially excited using lasers 
with wavelengths of 405 for DAPI, 488 (Leica) or 473 (Olympus) for 
Alexa Fluor 488, and 543 nm for Alexa Fluor 568. Z-series from the top 
to the bottom of fibers were sequentially collected for each channel with 
a step of 0.9–1 µm between each frame. Imaging was performed at 
room temperature using Type F immersion oil (Leica). Images (1024 × 
1024 pixels) were saved as TIFF files in Olympus FV-1000 software and 
Leica confocal software, and input levels were adjusted in Adobe Photo-
shop. Image quantification was performed using ImageJ (National Insti-
tutes of Health).
Image analysis
Striated surface measurement. The -actinin striated surface per myotube 
was quantified by manually drawing a region of interest in ImageJ around 
the striated or total cell surface in a single Z-stack from the middle of the 
cell. The striated surface was obtained by performing the ratio between 
striated and total myotube surface.
-Actinin aggregate size analysis. The “Analyze Particles” ImageJ plu-
gin (version 1.46) was used to count intracellular particles on binary confo-
cal images of C2C12 myotubes in a single Z-stack from the middle of the 
cell and to automatically measure the number and area of these particles.
shRNA constructs
The siRNA against CHC (CHC-1) used for in vitro transfection experiments 
was synthesized to be directly cloned in pSUPER under the control of the 
H1 promoter. ShRNA consisted of a 21-nt sense sequence followed by a 
9-nt loop (TTCAAGAGA), a 19-nt reverse sequence, and an RNA pol III 
terminator (TTTTT). The H1 cassette was then introduced into an AAV1-
based vector between the two ITRs using the blunted SpeI and SalI sites on 
pSUPER-shRNA plasmid and the XbaI site on the pSMD2 AAV2 vector 
backbones, which were type 1 pseudotyped (Généthon).
Virus production and titration
AAV2/1 pseudotyped vectors were prepared by transfection in 293 cells as 
described previously (Rivière et al., 2006) using the pSMD2-shRNA plasmid, 
the pXX6 plasmid (Généthon) coding for the adenoviral sequences essential 
for AAV production, and the pRepCAp plasmid (Généthon) coding for AAV1 
capsid. Vector particles were purified on iodixanol gradients and concen-
trated on Amicon Ultra-15 100K columns (EMD Millipore). The final viral prep-
arations were kept in PBS solution at 80°C. The particle titer (number of viral 
genomes) was determined by quantitative PCR. Titers for AAV shCHC were 
4 × 1012 vector genomes (vg)/ml.
In vivo gene transfer
Experiments were performed on adult 8-wk-old C57/BL6 mice. Anesthesia 
was achieved with a mix of 100 mg/kg ketamine and 10 mg/kg xylasine 
or using isoflurane. Two intramuscular injections (40 µl/TA), 24 h apart of 
AAV-shCHC, was performed in TA of the right hindlimb; the contralateral 
muscles were injected using the same procedure with control AAV vector 
(AAV-CTRL), which expresses the muSEAP protein (murine-secreted embry-
onic alkaline phosphatase). Mice were sacrificed at different intervals after 
the injection.
The presence of proteins in samples was detected using Western Lightning 
chemiluminescence reagent (GE Healthcare). Quantification was per-
formed using Quantity One software (Bio-Rad Laboratories).
Subcellular fractionation
3T3 fibroblasts, C2C12 myoblasts, and differentiated C2C12 myotubes 
were homogenized in HES buffer at pH 7.4 (20 mM Hepes, 1 mM EDTA, 
and 225 mM sucrose) by passing 10× through a 27-gauge needle. Homog-
enates were centrifuged for 20 min at 19,000 g. The resulting pellets were 
resuspended in HES buffer, layered on top of a 1.12-M sucrose cushion 
and centrifuged at 101,000 g for 60 min at 4°C. The PM fraction was col-
lected from the interface of the two solutions. Centrifugation of the initial 
supernatant (212,000 g) for 60 min at 4°C allowed separation of the intra-
cellular membrane fraction (pellet) and cytosol (supernatant).
Immunoprecipitation
For 3T3 and C2C12 subcellular fractions (PM and cytosol), 250 µl of each 
fraction was diluted to half using lysis buffer (50 mM Tris-HCl, pH 7.5, 
0.15 M NaCl, 1 mM EDTA, 1% NP-40, and 1 protease inhibitor cocktail 
tablet [1:10 ml buffer; Roche]). Mouse skeletal muscle tissue lysate (post-
nuclear supernatant) was diluted to 3 mg/ml in lysis buffer, precleared with 
30 µl washed protein G–Sepharose (PGS 4 fast flow; GE Healthcare) 
per 400 µl of diluted lysate, and incubated with 20 µg of specific anti-
body overnight (4°C). Then 30 µl washed PGS was added and incubated 
for 1 h at 4°C. Pelleted PGS was taken up in sample buffer and subjected 
to electrophoresis and immunoblotting. For all immunoprecipitation experi-
ments, HRP-conjugated rabbit and mouse IgG TrueBlot secondary antibod-
ies (eBioscience) were used.
Dissociated fiber cultures
Myofibers were isolated from the dissected FDB muscle of 6-wk-old mice by 
digestion with collagenase 1a (Worthington Biochemical Corporation) and 
mechanical dissociation. Isolated fibers were cultured (37°C, 5% CO2) in 
DMEM with high glucose, 1% horse serum (Gibco), and penicillin/strepto-
mycin on coverslips coated with Matrigel (BD). Myofibers were transduced 
with 70 µl of AAV vector (7 × 1010 viral genomes/well) for 12 d.
Mouse myoblast cultures
Primary skeletal muscle cells and C2C12 cells were maintained in tissue 
culture dishes coated with rat tail collagen in basal medium with 20% fetal 
bovine serum (FBS), 50 U/ml penicillin, and 50 mg/ml streptomycin 
(growth medium). Differentiation was induced when cells were 80% con-
fluent by culturing in differentiation medium (basal medium with 2% horse 
serum). For siRNA treatment, cells (differentiated for either 4 or 6 d) were 
transfected using 10 nM siRNA and transfection reagent (jetPRIME; Poly-
Plus Transfection) according to the manufacturer’s instructions. Targeting 
and GAPDH-specific control siRNAs were synthesized by Eurogentec. For 
CHC, sequences targeted were similar to those used in Ezratty et al. (2009): 
5-AACAUUGGCUUCAGUACCUUG-3 for CHC-1, 5-AAUGGAUCU-
CUUUGAAUACGG-3 for CHC-2, and 5-GAGCAUGUGCACGCUGGC-
CAGCU-3 for the -subunit of AP2. The GAPDH siRNA sequence was 
5-AAAGUUGUCAUGGAUGACC-3 and was used as a negative control 
in all siRNA experiments. The sequence of the siRNA specific for the -subunit 
of the AP1 complex (-adaptin) was 5-AGCUAUGAAUGAUAUAUUA-3, 
which is similar to the sequence used in Dugast et al. (2005) and Braun 
et al. (2007). The sequence of the siRNA specific for the -subunit of the 
AP3 complex (-adaptin) was 5-CAUCAAGAUCAUCAAGCUG-3, which 
is similar to the sequence used in Braun et al. (2007). The sequence of the 
siRNA specific for DNM2 was 5-ACCUACAUCAGGGAGCGAGAA-3. 
The sequence of the siRNA specific for Hip1R was 5-AACUCCUGCA-
CAGACCUGAUG-3, which is similar to the sequence used in Engqvist-
Goldstein et al. (2004). For CHC depletion, cells were transfected twice for 
48 h. For all other siRNA constructs, cells were transfected once for 48–72 h.
Immunofluorescence microscopy
Adult mouse skeletal muscle was embedded in Tissue-Tek OCT compound 
(Miles, Inc.), frozen, and stored at 80°C. Cryosections (10-µm thick) 
were fixed (15 min, 4% paraformaldehyde in PBS or 10 min, 95% ethanol 
[Fig. 1 D] at room temperature [RT]), permeabilized (5 min, 0.5% Triton 
X-100 in PBS at RT), and blocked (30 min, PBS with 0.1% Triton X-100, 5% 
bovine serum albumin [BSA]). Sections were incubated with primary anti-
bodies (overnight, 4°C, in PBS with 0.1% Triton X-100 and 5% BSA) and 
washed in PBS with 0.1% Triton X-100. Sections were then incubated with 
secondary antibodies (60 min at RT), washed in PBS with 0.1% Triton 
X-100, and mounted with anti-fading solution (DABCO) containing 
300 nM DAPI. For double labeling, the two primary antibodies (from different 
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Dual-Mode Lever; Aurora Scientific). Muscles were directly stimulated by a 
bipolar silver electrode using a supramaximal (80 V) square wave pulse of 
0.1-ms duration. Absolute maximal force (P0) was measured during isomet-
ric contractions in response to electrical stimulation (frequency of 25–150 
Hz; train of stimulation of 500 ms). All isometric contraction measurements 
were made at optimal muscle length (L0) at which P0 was obtained. TA 
muscles were weighted and specific maximal force (sP0) was calculated by 
dividing P0 by muscle weight.
Statistics and institutional guideline compliance
Statistical analysis was performed using Student’s t test except as otherwise 
stated. All animal studies were performed in compliance with the French 
government guidelines.
Online supplemental material
Fig. S1 shows ultrastructural analysis of tannic acid–stained muscle sec-
tions, anti-CHC–labeled muscle sections, and ultrastructural localization of 
clathrin in clathrin-coated pits and plaques of unroofed mouse primary 
myotubes. Fig. S2 displays additional images of -actinin localization and 
localization of 5-integrin in clathrin plaques of mouse primary myotubes. 
Fig. S3 shows efficiency of siRNA-mediated AP1, AP2, AP3, DNM2, and 
Hip1R depletion, the effect of siRNA-mediated AP2 depletion on CHC dis-
tribution, and localization of Hip1R in control and CHC- or AP2-depleted 
myotubes. Fig. S4 compares the effect of siRNA-mediated depletion of 
CHC, AP1, AP2, Hip1R, and DNM2 on actin distribution, and character-
izes localization of DNM2 in control or CHC- and AP2-depleted myotubes. 
Fig. S5 shows that in vivo CHC depletion induces a strong inflammatory 
response but has no effect of -dystroglycan and dystrophin distribution. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.201309096/DC1. Additional data are available in the 
JCB DataViewer at http://dx.doi.org/10.1083/jcb.201309096.dv.
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